# Hawrych v. Nutra-Luxe MD LLC

> District Court, M.D. Florida · April 21, 2022

URL: https://www.frixlaw.com/law-library/cases/10110003

## Case

- **Court:** District Court, M.D. Florida
- **Decided:** April 21, 2022
- **Opinion:** 100trialcourt
- **Cited by:** 0 later opinions in the Frix Law Library

## Citator (automated)

- No negative treatment found by the automated citator. That is not the same as a confirmation that the case is good law; read the citing cases.
- Full citator and citing cases: https://www.frixlaw.com/law-library/cases/10110003

## Opinion text

UNITED STATES DISTRICT COURT
MIDDLE DISTRICT OF FLORIDA
FORT MYERS DIVISION

ANDREW HAWRYCH, M.D.,

Plaintiff,

v. Case No.: 2:21-cv-830-SPC-MRM

NUTRA-LUXE M.D., LLC,
NUTRALUXE GLOBAL, LLC,
PETER VON BERG, and LASH
HOLDCO, LLC,

Defendants.
/
OPINION AND ORDER1
Before the Court are Nutra-Luxe, M.D., LLC and Peter Von Berg’s
Motion to Dismiss (Doc. 55), Nutraluxe Global, LLC and Lash Holdco, LLC’s
Motion to Dismiss (Doc. 56), along with Plaintiff Dr. Andrew Hawrych’s
Responses in Opposition (Doc. 57, Doc. 58). For the following reasons, the
Court grants the Motions and declines to exercise supplemental jurisdiction
over the state law claims that remain.

1 Disclaimer: Documents hyperlinked to CM/ECF are subject to PACER fees. By using
hyperlinks, the Court does not endorse, recommend, approve, or guarantee any third parties
or the services or products they provide, nor does it have any agreements with them. The
Court is also not responsible for a hyperlink’s availability and functionality, and a failed
hyperlink does not affect this Order.
BACKGROUND2
Nearly twenty years ago, Plaintiff Dr. Andrew Hawrych, a plastic

surgeon, and Defendant Peter Von Berg, a businessman operating a cosmetics
and skin care company, formed an oral agreement to develop new cosmetic
products. (Doc. 54 at ¶¶ 10, 11). Early in their relationship, Dr. Hawrych was
paid monthly for his research, development, and promotional work. (Doc. 54

at ¶ 13). But when Von Berg’s businesses experienced financial troubles, the
parties changed their arrangement. (Doc. 54 at ¶ 14–17). In exchange for Dr.
Hawrych’s continued commitment, and instead of monthly compensation, Von
Berg offered Dr. Hawrych a 10% ownership interest in Nutra-Luxe M.D., LLC.

(Doc. 54 at ¶ 17). Dr. Hawrych agreed, and he worked for Nutra-Luxe and Von
Berg under this arrangement for sixteen years. (Doc. 54 at ¶18).
Because of Dr. Hawrych’s association, Von Berg incorporated the
acronym “M.D.” into the company name, added the phrase “physician

developed/formulated” to the product descriptions, and used Dr. Hawrych’s
name, likeness, and trademark (“Hawrych MD”) in various advertisements.
(Doc. 54 at ¶¶ 19–23; Doc. 54-1).

2 The Court recounts the factual background as pled in the Amended Complaint, which it
must take as true to decide whether the Amended Complaint states a plausible claim. See
Chandler v. Sec’y of Fla. Dep’t of Transp., 695 F.3d 1194, 1198–99 (11th Cir. 2012) (per
curiam).
Although Von Berg “continuously confirmed” that Dr. Hawrych would
receive the value of his ownership interest when the company was sold, Von

Berg sold Nutra-Luxe to Lash HoldCo, LLC without notice or compensation to
Dr. Hawrych. (Doc. 54 at ¶¶ 25–26). Nutraluxe Global was formed after the
sale and is the successor to Nutra-Luxe’s assets. (Doc. 54 at ¶ 27).
After he was denied his promised 10% of the sale proceeds, Dr. Hawrych

revoked permissions and licenses that he had granted Defendants for the use
of his name, image, and trademark. (Doc. 54 at ¶¶ 28–30). After September
2021, Dr. Hawrych had severed himself from the research, development, and
sale of Defendants’ products. Dr. Hawrych then sued Von Berg, Nutra-Luxe,

Lash, and Global.3
LEGAL STANDARD
Together, Federal Rules of Civil Procedure 8 and 10 establish the
minimum pleading requirements. A complaint must contain “a short and plain

statement of the claim showing that the pleader is entitled to relief.” Fed. R.
Civ. P. 8(a)(2). And each “party must state its claims or defenses in numbered
paragraphs, each limited as far as practicable to a single set of circumstances.”
Fed. R. Civ. P. 10(b).

3 The Court will refer to Lash and Global collectively as “Lash-Global.”
A defendant can attack a complaint for not stating a claim upon which
relief can be granted. Fed. R. Civ. P. 12(b)(6). To survive a Rule 12(b)(6)

motion, “a complaint must contain sufficient factual matter, accepted as true,
to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556
U.S. 662, 678 (2009) (internal quotation marks omitted). A party must plead
more than “labels and conclusions, and a formulaic recitation of the elements

of a cause of action will not do.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555
(2007).
In considering a motion to dismiss, a court must accept all factual
allegations in a complaint as true and take them in the light most favorable to

the plaintiff. See Pielage v. McConnell, 516 F.3d 1282, 1284 (11th Cir. 2008)
(citation omitted). But acceptance of a complaint’s allegations is limited to
well-pled allegations. See La Grasta v. First Union Sec., Inc., 358 F.3d 840,
845 (11th Cir. 2004) (citations omitted).

DISCUSSION
Defendants challenge four counts of Dr. Hawrych’s seven-count
Amended Complaint: Count I, which alleges false advertising under the
Lanham Act, 15 U.S.C. § 1125; Count II, which alleges failure to pay minimum

wage under the Fair Labor Standards Act, 29 U.S.C. § 206; Count IV, which
alleges negligence; and Count VII, which alleges unjust enrichment.
Count I – False Advertising
To state a Lanham Act claim for false advertising, a plaintiff must allege

(1) the defendant’s statements were false or misleading; (2) the statements
deceived, or could deceive, consumers; (3) the deception had a material effect
on the consumers’ purchasing decision; (4) the misrepresented service affects
interstate commerce; and (5) the plaintiff has been, or likely will be, injured

because of the false or misleading statement. See Johnson & Johnson Vision
Care, Inc. v. 1-800 Contacts, Inc., 299 F.3d 1242, 1247 (11th Cir. 2002). Lash-
Global’s challenge to Count I, and the Court’s analysis, will focus on the first
element: whether Dr. Hawrych sufficiently alleged that Lash-Global’s

statements were false or misleading.
Lash-Global argues Count I fails because the Amended Complaint
alleges no false or misleading statement. Lash-Global points out that Dr.
Hawrych explicitly alleges that he developed the products at issue (Doc. 54 at

¶¶ 20, 55, 76, 99), therefore, Lash-Global’s advertisements stating that Dr.
Hawrych developed their products are truthful. Lash-Global contends that
because a true statement cannot support a false advertising claim, Count I
should be dismissed.

Dr. Hawrych responds that he is no longer involved in the research,
development, and marketing of Lash-Global’s products, and while the
representations in the marketing materials are true, they are “misleading as
to his present involvement.” (Doc. 58 at ¶¶ 12, 13).

The Amended Complaint includes these allegations about Lash-Global’s
statements:
• Dr. Hawrych’s involvement gave Von Berg and Nutra-Luxe the
ability to use the acronym “M.D.” in the company’s name, which

“demonstrated that there was some involvement from a medical
professional which could . . . assure consumers of the products [sic]
reliability” (Doc. 54 at ¶ 19);
• Nutra-Luxe’s product descriptions included the phrase “physician

developed/formulated” because of Dr. Hawrych’s involvement
(Doc. 54 at ¶ 20);
• Dr. Hawrych gave Von Berg and Nutra-Luxe the right to use his
name, likeness, and registered trademark “Hawrych MD,” and

Nutra-Luxe included those items in various advertisements (Doc.
54 at ¶¶ 22, 23);
• In September 2021, after the sale of Nutra-Luxe, Dr. Hawrych
revoked permission for the use of his name, image, and trademark;

and he severed himself from the research, development, and sale
of Nutra-Luxe products (Doc. 54 at ¶¶30, 42);
• After Dr. Hawrych had revoked permissions and licenses that he
had granted Defendants for the use of his name, image, and

trademark, Lash-Global has said its “products were developed by
Hawrych and [has] included Hawrych’s name on their products as
listed on their websites,” and it has marketed its products using
terms identical or similar to “Dr. Hawrych” and “Dr. A. Hawrych”

(Doc. 54 at ¶¶ 43, 44);
• Lash-Global’s use of Dr. Hawrych’s image, likeness, and
trademark give the misleading impressions that Dr. Hawrych is
involved in manufacturing Lash-Global’s products, that he is

associated or connected with Lash-Global, and that Lash-Global
continues to have his sponsorship, endorsement, consent, or
approval (Doc. 54 at ¶ 41).
And attached to the Amended Complaint4 are screenshots of

NutraLuxe’s product descriptions, stating, “[t]his revolutionary technology
was clinically researched, physician formulated and tested by A. Hawrych MD,
A Board Certified Facial Plastic Surgeon” (Doc. 54-2 at 3), and, “Dr. Hawrych’s
most advanced skin serum is formulated with two neuro-peptide ingredients”

(Doc. 54-2 at 6).

4 “A district court can generally consider exhibits attached to a complaint in ruling on a
motion to dismiss.” Hoefling v. City of Miami, 811 F.3d 1271, 1277 (11th Cir. 2016).
The statements that support Dr. Hawrych’s false advertisement claim
tout his involvement in the research, formulation, and testing of Nutra-Luxe’s

products. And Dr. Hawrych admits to this involvement. (Doc. 54 at ¶¶ 20, 55,
76, 99). So the statements accurately reflect Dr. Hawrych’s relationship to the
products. See Webster v. Dean Guitars, 955 F.3d 1270, 1277 (11th Cir. 2020)
(the statements central to the plaintiff’s false advertising claim were accurate

and not actionable where the plaintiff was involved in creating an original
guitar, and the company selling reissues of that guitar used videos depicting
that involvement in its advertisements for the reissues). Statements
conveying Dr. Hawrych’s role in the research, formulation, and testing of

Nutra-Luxe’s products are not rendered misleading because his relationship
with the company producing the products has changed.
The statements that support Dr. Hawrych’s false advertising claim are
accurate. This is not disputed. Count I is dismissed.

Count II – FLSA Failure to Pay Minimum Wage
To state a claim for failure to pay minimum wage under the FLSA, Dr.
Hawrych must allege (1) he was employed by Von Berg or Nutra-Luxe; (2) Von
Berg or Nutra-Luxe engaged in interstate commerce; and (3) Von Berg or

Nutra-Luxe failed to pay Dr. Hawrych minimum wage. See Morgan v. Family
Dollar Stores, Inc., 551 F.3d 1233, 1277 n.68 (11th Cir. 2008); Sec’y of Lab. v.
Labbe, 319 F. App’x 761, 763 (11th Cir. 2008) (per curiam). Here, the
sufficiency of Count II depends on whether the Amended Complaint
adequately alleges an employment relationship with either Von Berg or Nutra-

Luxe.
The FLSA defines “employee” as “any individual employed by an
employer.” 29 U.S.C. § 203(e)(1). A person is “employed” when an employer
“suffer[s] or permit[s] [the employee] to work.” Id. § 203(g). And an “employer”

includes “any person acting directly or indirectly in the interest of an employer
in relation to an employee.” Id. § 203(d). Courts use the “economic reality”
test5 to examine the circumstances surrounding a relationship to determine
whether an individual is an employee. Villarreal v. Woodham, 113 F.3d 202,

205 (11th Cir. 1997).
Von Berg and Nutra-Luxe raise two challenges to Dr. Hawrych’s wage
and hour claim. First, they argue Dr. Hawrych is an exempt professional who
has no FLSA claim. Second, they contend Dr. Hawrych fails plausibly to plead

that either Von Berg or Nutra-Luxe were his employer. Given these
deficiencies, they argue Count II should be dismissed with prejudice.
In response, Dr. Hawrych maintains he is not an exempt professional
because he was not engaged in the practice of medicine or compensated as a

5 Factors to be considered include: “whether the alleged employer (1) had the power to hire
and fire the employees, (2) supervised and controlled employee work schedules or conditions
of employment, (3) determined the rate and method of payment, and (4) maintained
employment records.” Villarreal, 113 F.3d at 205 (citation omitted).
“professional” while he worked for Von Berg and Nutra-Luxe. Dr. Hawrych
also insists that both Von Berg and Nutra-Luxe were his employers under the

FLSA.
The Court agrees that Dr. Hawrych has not stated a claim for failure to
pay minimum wages under the FLSA, but not for the reasons argued by Von
Berg and Nutra-Luxe.

Dr. Hawrych worked over thirty hours each week researching, testing,
developing, designing, and promoting cosmetic products for Nutra-Luxe. (Doc.
54 at ¶ 58). He attended weekly business meetings and board meetings,
represented the company at trade shows, and operated the company’s Amazon

account. (Doc. 54 ¶¶ 59–60). He also granted Von Berg and Nutra-Luxe
permission to incorporate “M.D.” into the company name, to add the phrase
“physician developed/formulated” to the product descriptions, and to use Dr.
Hawrych’s name, likeness, and trademark (“Hawrych MD”) in various

advertisements. (Doc. 54 at ¶¶ 19–23; Doc. 54-1). And Dr. Hawrych did this
for sixteen years with no compensation. (Doc. 54 at ¶¶ 16, 17, 18, 29, 31).
These are not the actions of an employee. These are the actions of a
stakeholder.

Early in their relationship, Von Berg compensated Dr. Hawrych monthly
for his services. (Doc. 54 at ¶ 13). But when Von Berg reported financial
difficulties, Dr. Hawrych agreed to continue providing the same services for no
pay. (Doc. 54 at ¶¶ 15–18). Instead, he was promised a 10% ownership interest
in Nutra-Luxe. (Doc. 54 at ¶ 17).

At that point, the relationship changed from one of arguable
“employment” to a joint venture, in which Dr. Hawrych contributed sweat
equity to the company with the expectation of a payout once the company was
sold. Looking at the economic realities of this relationship, there was no

employee/employer relationship. See Escobar v. GCI Media, Inc., No. 08-
21956-CIV, 2009 WL 1758712, at *6 (S.D. Fla. June 22, 2009) (because plaintiff
was a partner, not an employee, he was not protected by the FLSA); Godoy v.
Rest. Opportunity Ctr. of New York, Inc., 615 F. Supp. 2d 186, 195 (S.D.N.Y.

2009) (because plaintiffs and defendants were putative co-owners of a
restaurant they were working collectively to create, plaintiffs were not
employees and had no claims under the FLSA); Alperstein v. Irvin B. Foster &
Sons Sportswear Co., 193 F. Supp. 161, 162–63 (E.D. Pa. 1961) (plaintiff’s

willingness to work without compensation precluded conclusion he was an
employee).
The parties focus on whether Dr. Hawrych was an “exempt” employee
under the FLSA. But Count II fails because, given the economic realities of his

relationship with Von Berg and Nutra-Luxe, Dr. Hawrych was not an
employee. Count II is dismissed.
Count IV – Negligence
The four elements of a negligence claim are duty, breach of that duty,

proximate cause, and actual loss or damage. Jackson Hewitt, Inc. v. Kaman,
100 So. 3d 19, 27–28 (Fla. Dist. Ct. App. 2011). Breach, causation, and
damages are questions of fact, but “the determination of whether a duty is
owed presents a question of law.” Id. at 28 (citation omitted). And if it is

determined that no duty exists, a negligence claim fails. Id. at 28 (citation
omitted).
“It is a fundamental, long-standing common law principle that a plaintiff
may not recover in tort for a contract dispute unless the tort is independent of

any breach of contract.” Alvarez Rodriguez v. Branch Banking & Tr. Co., No.
1:19-cv-25191, 2020 WL 5640399, at *3 (S.D. Fla. July 9, 2020) (quoting Island
Travel & Tours, Ltd., Co. v. MYR Indep., Inc., 300 So. 3d 1236, 1240 (Fla. Dist.
Ct. App. 2020) (per curiam)). A “tort is independent if the plaintiff must prove

facts separate and distinct from the breach of contract.” Id. at *3 (citation and
quotation marks omitted). And damages resulting from an independent tort
“must be independent, separate and distinct from the damages sustained from
the contract’s breach.” Id. at *3 (quoting Peebles v. Puig, 223 So. 3d 1065, 1068

(Fla. Dist. Ct. App. 2017)).
The allegations supporting Dr. Hawrych’s negligence claim are (1) Von
Berg sold Nutra-Luxe to Lash without notice to Dr. Hawrych (Doc. 54 at ¶ 26);
(2) Dr. Hawrych did not receive his 10% interest in the sales proceeds (Doc. 54
at ¶ 28); (3) Von Berg and Nutra-Luxe failed to exercise their duty of care in

disclosing Dr. Hawrych’s 10% ownership of Nutra-Luxe (Doc. 54 at ¶¶ 92, 95);
(4) Lash-Global failed to exercise its duty of care in investigating and
discovering Dr. Hawrych’s 10% ownership of Nutra-Luxe (Doc. 54 at ¶¶ 92, 94);
and (5) these failures damaged Dr. Hawrych by depriving him of his 10% of the

value of Nutra-Luxe (Doc. 54 at ¶¶ 96, 97).
Negligence as to Von Berg and Nutra-Luxe
Von Berg and Nutra-Luxe attack Count IV on two grounds. First, they
argue that the Amended Complaint fails to show they owed Dr. Hawrych a

duty of care. And second, that the Amended Complaint fails to state a tort
claim independent of the breach of contract claim.
Dr. Hawrych counters that Von Berg and Nutra-Luxe had a general duty
of reasonable care in performing their contractual obligation, and he claims

that the independent tort rule is inapplicable because of the limitations the
Florida Supreme Court placed on it in Tiara Condo. Association, Inc. v. Marsh
& McLennan Companies, Inc., 110 So. 3d 399 (Fla. 2013).
The second argument Von Berg and Nutra-Luxe raise is dispositive. In

Tiara, the Florida Supreme Court explained, “the economic loss rule is a
judicially created doctrine that sets forth the circumstances under which a tort
action is prohibited if the only damages suffered are economic losses.” 110 So.
3d at 401. The Court limited the doctrine’s application to cases involving
products liability. Id. at 407. But in her concurring opinion, Justice Pariente

clarified that the Court’s holding did not depart from common law principles
that restrict tort remedies for parties to a contract. Id. at 408 (Pariente, J.,
concurring). “For example, in order to bring a valid tort claim, a party still
must demonstrate that all of the required elements for the cause of action are

satisfied, including that the tort is independent of any breach of contract
claim.” Id. (Pariente, J., concurring).
Here, the same underlying conduct gives rise to Dr. Hawrych’s breach of
contract claim and his negligence claim, as it relates to Von Berg and Nutra-

Luxe. For the breach of contract claim, the Amended Complaint alleges Mr.
Von Berg and Nutra-Luxe breached their contract with Hawrych by selling
Nutra-Luxe and then failed to pay Hawrych his 10% of the proceeds. (Doc. 54
at ¶ 81). For the negligence claim, the Amended Complaint alleges Von Berg

and Nutra-Luxe failed to exercise its purported duty of care in disclosing Dr.
Hawrych’s 10% ownership of Nutra-Luxe and, by extension, deprived him of
his 10% of the proceeds. (Doc. 54 at ¶¶ 92, 95–97). The negligence claim
alleges no facts separate and distinct from the breach of contract claim. And

there is no allegation of damages flowing from negligence that are
independent, separate, and distinct from the damages resulting from the
contract’s breach.
There are no facts or damages alleged in Dr. Hawrych’s negligence claim
that are independent, separate, and distinct from his breach of contract claim.

Thus, the negligence claim is dismissed. See Alvarez Rodriguez, 2020 WL
5640399, at *4 (quoting Peebles, 223 So. 3d at 1068); ESJ JI Operations, LLC
v. Domeck, 309 So. 3d 248, 250 (Fla. 3d DCA 2020) (collecting cases).
Negligence as to Lash-Global

Lash-Global also argues the Amended Complaint fails to establish it
owed Dr. Hawrych a legal duty. It urges the Court to conclude there was no
special relationship between Lash-Global and Dr. Hawrych and that it would
be improper to hold Lash-Global accountable for failing to perform by alleged

bad actors Von Berg and Nutra-Luxe. (Doc. 56 at ¶¶ 12–13).
Dr. Hawrych responds that he was owed a duty of care because he was
within a foreseeable zone of risk created by Lash-Global’s actions in purchasing
Nutra-Luxe’s business and assets. He contends that “[h]ad [Lash-Global]

properly investigated [Nutra-Luxe’s] corporate structure to discover
Hawrych’s ownership, [it] would have had to purchase [Nutra-Luxe] from
Hawrych as well.” (Doc. 58 at ¶ 68).
Determining the existence of a legal duty is not straightforward when a

negligence claim is based on only economic loss; the question turns on whether
the relationship between the parties “warrants creating a duty to protect
economic interests outside contract and statutory law.” Tank Tech, Inc. v.
Valley Tank Testing, L.L.C., 244 So. 3d 383, 393 (Fla. 2d DCA 2018) (quoting
Monroe v. Sarasota Cnty. Sch. Bd., 746 So. 2d 530, 534 n.6 (Fla. 2d DCA 1999)).

“Thus, in order to proceed on a common law negligence claim based solely on
economic loss, there must be some sort of link between the parties or some
other extraordinary circumstance that justifies recognition of such a claim.”
Id. at 393 (collecting cases).

In Curd v. Mosaic Fertilizer, LLC, the Florida Supreme Court held, based
on the extraordinary circumstances in the case, that a duty existed between
two parties that did not have contractual privity. 39 So. 3d 1216, 1228 (Fla.
2010). There, the Court reasoned a fertilizer company owed a commercial

fisherman a special duty because of the nature of the company’s business
(storage of pollutants and hazardous chemicals near Tampa Bay) and the
fisherman’s peculiar interest in the health of the public waters. Id.
Dr. Hawrych has alleged a peculiar interest in the Nutra-Luxe brand

and products, but that is only part of the equation. Unlike in Curd, there is
nothing extraordinary about the nature of Lash-Global’s business or its
dealings with Von Berg and Nutra-Luxe. It simply executed a transaction in
pursuit of a business opportunity. This is an everyday occurrence.

Furthermore, “Eleventh Circuit precedents confirm that, in the
commercial context, defendants are unlikely to owe a duty of care to strangers.”
Kelly v. Davis, No. 3:10CV392-MW/EMT, 2014 WL 12515345, at *4 (N.D. Fla.
July 17, 2014); see also Virgilio v. Ryland Group, Inc., 680 F.3d 1329, 1340–41
(11th Cir. 2012); Kafka v. Wachovia Bank, N.A., 218 F. App’x 960, 962 (11th

Cir. 2007) (per curiam).
While Dr. Hawrych was not a stranger—his name was showcased from
the company name to the product descriptions—he did not have a relationship,
let alone a special relationship, with Lash-Global that would impose a duty

toward him. From Lash-Global’s vantage, Dr. Hawrych was somehow
associated with Von Berg and Nutra-Luxe, the opposing party in an arm’s-
length transaction.
In Virgilio, the Eleventh Circuit considered and rejected imposing an

“affirmative duty on a developer, or on an entity that promotes a residential
development, to publicly disclose material facts that may negatively affect the
economic value of a home that the developer did not build, own or sell.” 680
F.3d at 1334, 1339–41. But Dr. Hawrych goes further. He asks the Court to

impose on contracting parties the affirmative duty to investigate the truth of
representations made during an arm’s-length transaction to safeguard the
interests of those associated with their counterparts. Dr. Hawrych asks too
much.

When the plaintiff seeks only the recovery of an economic loss, the duty
element of negligence law serves as an important barrier to over-extension of
liability. Id. at 1339–40 (citation omitted). To conclude that a duty exists here
would be just such an over-extension of liability. Count IV is dismissed.

Count VII – Unjust Enrichment
“A claim for unjust enrichment has three elements: (1) the plaintiff has
conferred a benefit on the defendant; (2) the defendant voluntarily accepted
and retained that benefit; and (3) the circumstances are such that it would be

inequitable for the defendants to retain it without paying the value thereof.”
Id. at 1337 (citations omitted). “[A]s to the first element, the benefit conferred
on the defendant must be a direct benefit.” Johnson v. Catamaran Health
Sols., LLC, 687 F. App’x 825, 830 (11th Cir. 2017) (per curiam) (citing Kopel v.

Kopel, 229 So. 3d 812, 818 (Fla. 2017)). And “w[h]en a defendant has given
adequate consideration to someone for the benefit conferred, a claim of unjust
enrichment fails.” Am. Safety Ins. Serv., Inc. v. Griggs, 959 So. 2d 322, 331–32
(Fla. Dist. Ct. App. 2007) (collecting cases).

Lash-Global challenges Dr. Hawrych’s unjust enrichment claim on two
grounds: first, Lash-Global was not unjustly enriched because it paid for any
benefit it received; and second, Dr. Hawrych did not directly confer a benefit
on Lash-Global.

Dr. Hawrych tries to distinguish the authorities supporting the first
argument, asserting that Lash-Global’s failure to investigate and verify Von
Berg’s representations before it bought Nutra-Luxe render Lash-Global’s
retention of the benefit unjust. In response to the second argument, Dr.
Hawrych contends he conferred a direct benefit on Lash-Global, despite the

lack of direct contact.
The circumstances behind this case are this: Von Berg sold Nutra-Luxe
and its products to Lash; Global now possesses Nutra-Luxe’s former assets;
Von Berg did not pay Dr. Hawrych his 10% interest from that sale. (Doc. 54 at

¶¶ 26, 27, 28). Lash-Global did not receive a windfall; it received the benefit
of its bargain. Under these circumstances it cannot be said that Lash-Global
has been unjustly enriched. And so, Count VII fails.
Count VII also fails because Dr. Hawrych did not directly confer a benefit

on Lash-Global. Two allegations in the Amended Complaint make this explicit.
First: “[Dr.] Hawrych provided labor, services, materials, his likeness,
expertise, the use of his registered and unregistered trademarks, creations and
time to [Nutra-Luxe] and [Mr. Von Berg] in the development of cosmetic

products, and thereby conferred a benefit on them.” (Doc. 54 at ¶ 121)
(emphasis added). And second: “Global . . . has retained all of [Dr.] Hawrych’s
benefits bestowed on [Nutra-Luxe].” (Doc. 54 at ¶ 122) (emphasis added).
Florida courts consistently hold that an unjust enrichment claim must

be based on a benefit directly conferred on the defendant. See, e.g., Kopel, 229
So. 3d at 818; Extraordinary Title Servs., LLC v. Fla. Power & Light Co., 1 So.
3d 400, 404 (Fla. Dist. Ct. App. 2009); Peoples Nat’l Bank of Com. v. First Union
Nat’l Bank of Fla., N.A., 667 So. 2d 876, 879 (Fla. Dist. Ct. App. 1996) (per
curiam). Dr. Hawrych conferred a direct benefit on Von Berg and Nutra-Luxe,

but he conferred no such benefit directly on Lash-Global. The allegations of
the Amended Complaint illustrate this.6 Count VII is dismissed.
Supplemental Jurisdiction
The Court has dismissed all the federal claims in this case. And though

a federal district court is given supplemental jurisdiction over state law claims
that “form part of the same case or controversy” as federal claims over which
it has original jurisdiction, a court “may decline to exercise supplemental
jurisdiction over [such] claim[s] . . . if . . . [it] has dismissed all claims over

which it has original jurisdiction.” See 28 U.S.C. § 1367(a), (c)(3).
“[P]endent jurisdiction is a doctrine of discretion, not of plaintiff’s right.”
United Mine Workers of Am. v. Gibbs, 383 U.S. 715, 726 (1966) (footnote
omitted); see also Raney v. Allstate Ins. Co., 370 F.3d 1086, 1088–89 (11th Cir.

2004) (per curiam) (citation omitted). And in these circumstances, the
Eleventh Circuit “strongly encourages” district courts to decline supplemental
jurisdiction. Mergens v. Dreyfoos, 166 F.3d 1114, 1119 (11th Cir. 1999).

6 Even if these allegations did not explicitly characterize the benefit as conferred directly to
Mr. Von Berg and Nutra-Luxe, the amended complaint makes clear that any connection
between Dr. Hawrych and Lash-Global was attenuated and that the circumstances
surrounding the sale of Nutra-Luxe belie any claim of a direct benefit flowing from Dr.
Hawrych to Lash-Global.
When deciding whether to exercise supplemental jurisdiction, district
courts should consider “concerns of comity, judicial economy, convenience,

fairness, and the like.” Cook ex rel. Est. of Tessier v. Sheriff of Monroe Cnty.,
Fla., 402 F.3d 1092, 1123 (11th Cir. 2005). After review, the Court employs its
discretion and declines to exercise supplemental jurisdiction over the
remaining state law claims. 28 U.S.C. § 1367(c)(3).

First, judicial economy weighs against exercising supplemental
jurisdiction. Judicial economy is “served when issues of state law are resolved
by state courts.” Rowe v. City of Fort Lauderdale, 279 F.3d 1271, 1288 (11th
Cir. 2002).

Second, convenience points to retaining jurisdiction—but only just. The
Eleventh Circuit has noted, “as far as the parties are concerned, it would be
most convenient to try every claim in a single forum.” Ameritox, Ltd. v.
Millennium Labs., Inc., 803 F.3d 518, 539 (11th Cir. 2015).

Third, fairness considerations do not favor jurisdiction here. Each
“litigant who brings supplemental claims in [federal] court knowingly risks the
dismissal of those claims.” Id. Because this case has not progressed past
Defendants’ motions to dismiss, it is still in the early stages of litigation. See

Raney, 370 F.3d at 1089 (encouraging district courts to dismiss remaining state
claims when the federal claim has been dismissed prior to trial).
Fourth, comity cuts against exercising supplemental jurisdiction. “It is
a bedrock principle that ‘needless decisions of state law should be avoided both

as a matter of comity and to promote justice between the parties, by procuring
for them a surer-footed reading of applicable law.’” Ameritox, 803 F.3d at 539
(quoting Gibbs, 383 U.S. at 726) (alteration omitted).
Finally, there are no concerns about the timeliness of Dr. Hawrych’s

claims because Section 1367(d) tolls the statutes of limitation for state claims
during the period in which they have been pending in federal court and for
thirty (30) days after an order of dismissal. See 28 U.S.C. § 1367(d); Jinks v.
Richland Cnty., 538 U.S. 456, 465 (2003) (upholding 28 U.S.C. § 1367(d) as

constitutional); Beck v. Prupis, 162 F.3d 1090, 1099–1100 (11th Cir. 1998) (“[A]
dismissal under section 1367 automatically tolls the statute of limitations on
the dismissed claims for 30 days”).
On balance, these factors weigh against the Court’s exercise of

supplemental jurisdiction.
CONCLUSION
Accordingly, it is now
ORDERED:

(1) Defendants’ Motions to Dismiss (Doc. 55, Doc. 56) are GRANTED.
Counts I, II, IV, and VII are DISMISSED with prejudice.
(2) The Court declines to exercise supplemental jurisdiction over the
remaining state claims; therefore, this action is DISMISSED without
prejudice.
(8) The Clerk is DIRECTED to deny any pending motions, terminate
all deadlines, enter judgment, and close this case.
DONE and ORDERED in Fort Myers, Florida on April 21, 2022.

UNITED STATES DISTRICT JUDGE

Copies: All Parties of Record

23

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/cases/10110003. Public record. Not legal advice.